EUTM file information

003222668

SANTARIS PHARMA


June 11, 2003

Trademark Summary

The trademark SANTARIS PHARMA was filed by Santaris Pharma A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on November 21, 2004, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on February 21, 2005 by Wyeth Holdings LLC on undefined. the opponent was represented by ELZABURU, S.L.P. and its proceedings were handled in English The second opposition filed on February 2, 2005 by SANTARUS, INC. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute, (c) Earlier non registered TM & right to prohibit use of later TM under national law, (d) Earlier sign & right to prohibit use of later TM under national law. the opponent was represented by MEWBURN ELLIS LLP and its proceedings were handled in English

The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).

The renewal of the trademark was recorded by the office on April 12, 2014.

of the trademark registration was recorded on April 12, 2014. Appointment and Replacement of representative of the trademark registration was recorded on October 27, 2003. Change of name and professional address of the trademark registration was recorded on November 23, 2006. Change of name and professional address of the trademark registration was recorded on August 19, 2007. Appointment and Replacement of representative of the trademark registration was recorded on February 3, 2009.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
    2. Reagents, nucleotides, and oligonucleotides and oligonucleotide analogues for scientific or medical research use, in particular reagents and nucleotides for the synthesis of oligonucleotides and oligonucleotide analogues as well as oligonucleotides and oligonucleotide analogues for use in the manufacture of diagnostic preparations, therapeutic preparations and pharmaceuticals
    3. Nucleotides, oligonucleotides and oligonucleotide analogues for gene therapy, as antisense or antisense treatment.
  • The mark was filed in class 5 with Pharmaceutical and veterinary preparations and diagnostic preparations as far as included in this class, all the aforementioned goods available on prescription only and expressly excluding dietary and nutritional supplements..
  • The mark was filed in class 42 with Scientific, medical and industrial research and scientific and industrial consultancy..